Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 7 studies | 23% ± 5% | |
| GABAergic neuron | 4 studies | 33% ± 16% | |
| type II pneumocyte | 4 studies | 21% ± 5% | |
| astrocyte | 4 studies | 40% ± 15% | |
| fibroblast | 3 studies | 41% ± 36% | |
| type I pneumocyte | 3 studies | 20% ± 4% | |
| glutamatergic neuron | 3 studies | 43% ± 16% | |
| interneuron | 3 studies | 45% ± 12% | |
| oligodendrocyte | 3 studies | 35% ± 10% | |
| oligodendrocyte precursor cell | 3 studies | 30% ± 12% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 37% ± 15% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| pancreas | 100% | 246.72 | 328 / 328 | 87% | 5.67 | 155 / 178 |
| stomach | 81% | 440.80 | 290 / 359 | 97% | 12.24 | 278 / 286 |
| prostate | 90% | 102.28 | 220 / 245 | 77% | 2.28 | 386 / 502 |
| intestine | 68% | 505.78 | 653 / 966 | 97% | 14.84 | 513 / 527 |
| lung | 84% | 40.64 | 485 / 578 | 61% | 2.82 | 703 / 1155 |
| bladder | 62% | 112.14 | 13 / 21 | 70% | 5.62 | 351 / 504 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.10 | 1 / 1 |
| spleen | 80% | 34.76 | 194 / 241 | 0% | 0 | 0 / 0 |
| breast | 45% | 23.90 | 208 / 459 | 34% | 1.70 | 384 / 1118 |
| esophagus | 15% | 5.84 | 217 / 1445 | 60% | 4.90 | 109 / 183 |
| tonsil | 0% | 0 | 0 / 0 | 73% | 2.70 | 33 / 45 |
| liver | 47% | 12.50 | 106 / 226 | 20% | 0.70 | 82 / 406 |
| ovary | 0% | 0 | 0 / 180 | 61% | 1.60 | 261 / 430 |
| lymph node | 0% | 0 | 0 / 0 | 59% | 2.89 | 17 / 29 |
| uterus | 8% | 1.96 | 14 / 170 | 47% | 1.47 | 217 / 459 |
| kidney | 29% | 9.53 | 26 / 89 | 1% | 0.03 | 13 / 901 |
| peripheral blood | 26% | 32.96 | 239 / 929 | 0% | 0 | 0 / 0 |
| skin | 9% | 1.95 | 157 / 1809 | 7% | 0.11 | 35 / 472 |
| thymus | 12% | 3.28 | 81 / 653 | 3% | 0.09 | 19 / 605 |
| brain | 8% | 1.62 | 209 / 2642 | 1% | 0.01 | 6 / 705 |
| adipose | 4% | 0.89 | 48 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 4% | 0.80 | 53 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 2% | 0.70 | 13 / 803 | 0% | 0 | 0 / 0 |
| adrenal gland | 1% | 0.19 | 3 / 258 | 0% | 0 | 0 / 230 |
| heart | 1% | 0.11 | 5 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006915 | Biological process | apoptotic process |
| GO_2001236 | Biological process | regulation of extrinsic apoptotic signaling pathway |
| GO_0043229 | Cellular component | intracellular organelle |
| GO_0012505 | Cellular component | endomembrane system |
| GO_0005829 | Cellular component | cytosol |
| GO_0016020 | Cellular component | membrane |
| GO_0019901 | Molecular function | protein kinase binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | BCL2L14 |
| Protein name | Apoptosis facilitator Bcl-2-like protein 14 (BCL2 like 14) Apoptosis facilitator Bcl-2-like protein 14 (Bcl2-L-14) (Apoptosis regulator Bcl-G) |
| Synonyms | BCLG |
| Description | FUNCTION: Plays a role in apoptosis. |
| Accessions | ENST00000396367.5 [Q9BZR8-1] C9K0Q9 ENST00000631317.2 [Q9BZR8-1] ENST00000628217 Q9BZR8 ENST00000629515 ENST00000586576.5 ENST00000628315.1 [Q9BZR8-3] ENST00000266434.8 [Q9BZR8-2] ENST00000627413.2 [Q9BZR8-1] ENST00000589718.5 [Q9BZR8-1] K7EKK7 ENST00000461264.1 ENST00000631251.2 [Q9BZR8-2] ENST00000627464 ENST00000298566.2 [Q9BZR8-3] C9J3S1 ENST00000625808 ENST00000308721.9 [Q9BZR8-1] K7EMX4 ENST00000588270.1 ENST00000628783.2 [Q9BZR8-1] ENST00000464885.6 |
